Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects
Clinical trial NCT01534403 · COMPLETED
Trial details
- NCT number
- NCT01534403
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.